Dr Cristina Ariani

Cristina leads the genomic surveillance operations for Covid-19 at the Wellcome Sanger Institute. She leads end-to-end services by championing change and continuous improvement, liaising with internal and external stakeholders. She is responsible for the continual development and day-to-day delivery of the Covid-19 sequencing service at the Wellcome Sanger Institute, ensuring collaboration across the internal delivery teams and a wide range of external stakeholders including Public Health Agencies and the Department of Health and Social Care.